A population-guided dynamic optimization mechanism for individual brain graphs, which feeds the stable disease-discriminative information learned at the population level back into the structural updating of individual brain graphs, thereby enhancing disease-related connections while suppressing site-related noisy connections.
Abstract
Major depressive disorder (MDD) is a brain disorder characterized by substantial individual heterogeneity, and its accurate diagnosis remains challenging in clinical practice. Graph neural networks applied to functional brain networks (FBNs) constructed from resting-state functional magnetic resonance imaging (rs-fMRI) data have shown promise for MDD diagnosis. However, in multicenter settings, site differences are often entangled with disease-related information, which not only interferes with the model's learning of disease patterns but also compromises the reliable modeling of topological patterns in individual FBNs, thereby limiting identification performance. To address this problem, we propose a disentangled population-guided graph neural network with dynamic refinement (DPGR-Net) for MDD identification. Specifically, DPGR-Net first constructs individual FBN from rs-fMRI data and learns discriminative subject-level brain graph representations. To mitigate the interference of site effects, we disentangle disease-related associations from site-related variations at the population level and impose an independence constraint to learn more stable cross-site disease-discriminative representations. On this basis, we innovatively design a population-guided dynamic optimization mechanism for individual brain graphs, which feeds the stable disease-discriminative information learned at the population level back into the structural updating of individual brain graphs, thereby enhancing disease-related connections while suppressing site-related noisy connections. Experimental results on the public REST-meta-MDD dataset show that the proposed method achieves an ACC of 92.37% and outperforms existing state-of-the-art methods. Furthermore, DPGR-Net identifies discriminative brain regions and aberrant functional connectivity patterns associated with MDD, thereby advancing the interpretability and clinical utility of rs-fMRI for MDD diagnosis.
BACKGROUND
Major depressive disorder (MDD) is a highly heterogeneous affective disorder, and the identification of reliable neuroimaging markers remains challenging. Resting-state functional magnetic resonance imaging offers a promising approach for characterizing altered brain functional organization in MDD. However,...
Ting Mei, Man-Yun Zhu, Hongbo Zhu et al.· Journal of Affective Disorde...· 0 citations
Experimental results on three large-scale fMRI datasets demonstrate that BrainCGT achieves consistently better performance than existing graph-based methods for neurological disorder classification, highlighting the importance of incorporating causal directionality into brain graph transformer architectures for robust...
Ahsan Shehzad, Dong-Yu Zhang, Shagufta Abid et al.· Proceedings of the Thirty-Fi...· 0 citations
Classification models based on resting-state functional magnetic resonance imaging (rs-fMRI) often show lower performance at imaging sites not included during model development, which can limit their use in clinical settings. Domain generalization (DG) addresses this issue by learning representations from source sites...
Muhammad Asif Hasan, Yan-Ming Zhu, Xuefei Yin et al.· 0 citations
Findings indicate that MDD is associated with altered multiscale functional organization, combining less compact global integration with an increased prevalence of cross-network hole-defining cycles, with these features varying systematically with illness course and current medication, suggesting that topology-informed...
Javier F. Castilla-Jiménez, Juan Carlos Díaz-Patiño, S. Enriquez-Geppert et al.· bioRxiv· 0 citations
It is concluded that while GNNs have significantly advanced the field, challenges remain in handling data heterogeneity, improving model robustness and interpretability, and achieving clinical translation.
Zi-Chao Shen· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.